Literature DB >> 30288850

Sensory disturbances induced by sensorimotor conflicts are higher in complex regional pain syndrome and fibromyalgia compared to arthritis and healthy people, and positively relate to pain intensity.

Clémentine Brun1,2, Catherine Mercier1,2, Sharon Grieve3,4, Shea Palmer4, Jacqueline Bailey5, Candida S McCabe3,4,6.   

Abstract

BACKGROUND: Sensorimotor conflicts are well known to induce sensory disturbances. However, explanations as to why patients with chronic pain are more sensitive to sensorimotor conflicts remain elusive. The main objectives of this study were (a) to assess and compare the sensory disturbances induced by sensorimotor conflict in complex regional pain syndrome (n = 38), fibromyalgia (n = 36), arthritis (n = 34) as well as in healthy volunteers (HV) (n = 32); (b) to assess whether these disturbances were related to the intensity and duration of pain, or to other clinical variables assessed using questionnaires (abnormalities in sensory perception, depression and anxiety); and (c) to categorize different subgroups of conflict-induced sensory disturbances.
METHODS: One hundred and forty participants performed in phase or anti-phase movements with their arms while viewing a reflection of one arm in a mirror (and the other arm obscured). They were asked to report changes in sensory disturbances using a questionnaire.
RESULTS: First, results showed that patients with complex regional pain syndrome and fibromyalgia were more prone to report sensory disturbances than arthritis patients and HV in response to conflicts (small effect size). Second, conflict-induced sensory disturbances were correlated with pain intensity (large effect size) and abnormalities in sensory perception (only in the CRPS group) but were not related to the duration of the disease or psychological factors. Finally, we identified two distinct subgroups of conflict-induced sensory disturbances.
CONCLUSIONS: Our results suggest that pain lowers the threshold for the detection of sensorimotor conflicts, a phenomenon that could contribute to the maintenance of pain in clinical populations. SIGNIFICANCE: Individuals with complex regional pain syndrome and fibromyalgia were more sensitive to sensorimotor conflicts than arthritis patients and controls. Moreover, conflict-induced sensory disturbances were specific to higher pain intensity and higher sensory abnormalities in all groups, suggesting that pain lowers the threshold for the detection of sensorimotor conflicts.
© 2018 European Pain Federation - EFIC®.

Entities:  

Mesh:

Year:  2018        PMID: 30288850     DOI: 10.1002/ejp.1322

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  5 in total

1.  Where is my arm? Investigating the link between complex regional pain syndrome and poor localisation of the affected limb.

Authors:  Valeria Bellan; Felicity A Braithwaite; Erica M Wilkinson; Tasha R Stanton; G Lorimer Moseley
Journal:  PeerJ       Date:  2021-08-20       Impact factor: 2.984

2.  Pain reduction by inducing sensory-motor adaptation in Complex Regional Pain Syndrome (CRPS PRISMA): protocol for a double-blind randomized controlled trial.

Authors:  Monika Halicka; Axel D Vittersø; Michael J Proulx; Janet H Bultitude
Journal:  BMC Neurol       Date:  2020-02-19       Impact factor: 2.474

3.  Visual Sensitivity in Complex Regional Pain Syndrome and Fibromyalgia: An Online Study.

Authors:  Antonia F Ten Brink; Janet H Bultitude
Journal:  Perception       Date:  2022-03-03       Impact factor: 1.490

Review 4.  Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS).

Authors:  Monika Halicka; Axel D Vittersø; Michael J Proulx; Janet H Bultitude
Journal:  Behav Neurol       Date:  2020-01-14       Impact factor: 3.342

5.  Impact of Experimental Tonic Pain on Corrective Motor Responses to Mechanical Perturbations.

Authors:  Elodie Traverse; Clémentine Brun; Émilie Harnois; Catherine Mercier
Journal:  Neural Plast       Date:  2020-07-31       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.